Joining us on “GEN Edge Live” were: Michelle Gilson, a managing director with Canaccord Genuity focused on biotechnology; her colleague Arlinda Lee, PhD, a Canaccord Genuity analyst; and Geulah Livshits, PhD, senior research analyst with Chardan covering biotech companies, with a focus on gene editing and oncology . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
The post “GEN Edge Live”: Analyzing the Latest Milestones in Genome Editing appeared first on GEN – Genetic Engineering and Biotechnology News.
